Recent events
Recent events tied to this brand in public sources.
Back to profile3 entries
2020
Aurinia and Otsuka announce voclosporin collaboration and licensing agreement
Aurinia announced a collaboration and license agreement with Otsuka for the development and commercialization of oral voclosporin for lupus nephritis in the European Union, Japan, the United Kingdom, Russia, Switzerland, Norway, Belarus, Iceland, Liechtenstein and Ukraine.
2020
Court approves Otsuka’s bid to acquire Proteus
A Delaware bankruptcy court approved Otsuka Pharmaceutical’s bid to acquire Proteus for $15 million in cash. The approval allows Otsuka to integrate Proteus’ business with its own; the article does not report that the acquisition has been completed.
2020
Responsum Health launches Responsum for CKD
Responsum Health, with support from Otsuka Pharmaceutical, announced the launch of Responsum for CKD, a free online and mobile platform for people with kidney disease. It provides curated health news, a moderated community space, patient information tools, and support links.